MUSTANG BIO, INC. Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities
MUSTANG BIO, INC. (MBIO) reported Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities · last filed 2021-03-24
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2020-12-31 was $0.00.
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2020-09-30 was $0.00.
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2019 was $17.60M, a 71.14% decline from fiscal 2018.
- MUSTANG BIO, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2018 was $61.00M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 3 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 6 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 9 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $0.00 derived: sum of 2 quarters · filed 2021-03-24 | $0.00 derived: sum of 3 quarters · filed 2021-03-24 | $0.00 10-K · filed 2021-03-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 4 quarters · filed 2021-03-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2021-03-24 | $0.00 derived: sum of 4 quarters · filed 2021-03-24 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-24 | $0.00 derived: sum of 3 quarters · filed 2021-03-24 | $5.10M derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $0.00 derived: sum of 2 quarters · filed 2021-03-24 | $5.10M derived: sum of 3 quarters · filed 2021-03-24 | $17.60M 10-K · filed 2021-03-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.10M derived: sum of 2 quarters · filed 2020-11-06 | $17.60M 10-Q · filed 2020-11-06 | $27.60M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $17.60M 10-Q · filed 2020-08-10 | $27.60M derived: sum of 3 quarters · filed 2020-08-10 | |
| 2019-03-31 | $12.50M 10-Q · filed 2020-05-11 | $22.50M derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $61.00M 10-K · filed 2020-03-16 | ||
| 2018-09-30 | $51.00M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |